1.
|
Huntley S, Baggott DM, Hamilton AT,
Tran-Gyamfi M, et al: A comprehensive catalog of human
KRAB-associated zinc finger genes: insights into the evolutionary
history of a large family of transcriptional repressors. Genome
Res. 16:669–677. 2006. View Article : Google Scholar : PubMed/NCBI
|
2.
|
Urrutia R: KRAB-containing zinc-finger
repressor proteins. Genome Biol. 4:2312003. View Article : Google Scholar : PubMed/NCBI
|
3.
|
Margolin JF, Friedman JR, Meyer WK,
Vissing H, et al: Krüppel-associated boxes are potent
transcriptional repression domains. Proc Natl Acad Sci USA.
91:4509–4513. 1994.
|
4.
|
Mark C, Abrink M and Hellman L:
Comparative analysis of KRAB zinc finger proteins in rodents and
man: evidence for several evolutionarily distinct subfamilies of
KRAB zinc finger genes. DNA Cell Biol. 18:381–396. 1999. View Article : Google Scholar : PubMed/NCBI
|
5.
|
Gou DM, Sun Y, Gao L, Chow LM, et al:
Cloning and characterization of a novel Krüppel-like zinc finger
gene, ZNF268, expressed in early human embryo. Biochim Biophys
Acta. 1518:306–310. 2001.
|
6.
|
Shao H, Zhu C, Zhao Z, Guo M, et al:
KRAB-containing zinc finger gene ZNF268 encodes multiple
alternatively spliced isoforms that contain transcription
regulatory domains. Int J Mol Med. 18:457–463. 2006.PubMed/NCBI
|
7.
|
Sun Y, Gou DM, Liu H, Peng X and Li WX:
The KRAB domain of zinc finger gene ZNF268: a potential
transcriptional repressor. IUBMB Life. 55:127–131. 2003. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Wang W, Guo M, Hu L, Cai J, et al: The
zinc finger protein ZNF268 is overexpressed in human cervical
cancer and contributes to tumorigenesis via enhancing NF-κB
signaling. J Biol Chem. 287:42856–42866. 2012.PubMed/NCBI
|
9.
|
Guo MX, Wang D, Shao HJ, Qiu HL, et al:
Transcription of human zinc finger ZNF268 gene requires an
intragenic promoter element. J Biol Chem. 281:24623–24636. 2006.
View Article : Google Scholar : PubMed/NCBI
|
10.
|
Sun Y, Shao H, Li Z, Liu J, et al: ZNF268,
a novel kruppel-like zinc finger protein, is implicated in early
human liver development. Int J Mol Med. 14:971–975. 2004.PubMed/NCBI
|
11.
|
Krackhardt AM, Witzens M, Harig S, Hodi
FS, et al: Identification of tumor-associated antigens in chronic
lymphocytic leukemia by SEREX. Blood. 100:2123–2131. 2002.
View Article : Google Scholar : PubMed/NCBI
|
12.
|
Wang D, Guo MX, Hu HM, Zhao ZZ, et al:
Human T-cell leukemia virus type 1 oncoprotein tax represses ZNF268
expression through the cAMP-responsive element-binding
protein/activating transcription factor pathway. J Biol Chem.
283:16299–16308. 2008. View Article : Google Scholar
|
13.
|
Zhao Z, Wang D, Zhu C, Shao H, et al:
Aberrant alternative splicing of human zinc finger gene ZNF268 in
human hematological malignancy. Oncol Rep. 20:1243–1248.
2008.PubMed/NCBI
|
14.
|
Zeng Y, Wang W, Ma J, Wang X, et al:
Knockdown of ZNF268, which is transcriptionally downregulated by
GATA-1, promotes proliferation of K562 cells. PLoS One.
7:e295182012. View Article : Google Scholar : PubMed/NCBI
|
15.
|
Jemal A, Bray F, Center MM, Ferlay J, et
al: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011.
View Article : Google Scholar
|
16.
|
Marugame T and Hirabayashi Y: Comparison
of time trends in ovary cancer incidence (1973–1997) in East Asia,
Europe, and the USA, from Cancer Incidence in Five Continents Vols
IV VIII. Jpn J Clin Oncol. 37:802–803. 2007.PubMed/NCBI
|
17.
|
Agarwal R and Kaye SB: Ovarian cancer:
strategies for overcoming resistance to chemotherapy. Nat Rev
Cancer. 3:502–516. 2003. View
Article : Google Scholar : PubMed/NCBI
|
18.
|
Paley PJ: Ovarian cancer screening: are we
making any progress? Curr Opin Oncol. 13:399–402. 2001. View Article : Google Scholar : PubMed/NCBI
|
19.
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: new opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
20.
|
Ropponen KM, Eskelinen MJ, Lipponen PK,
Alhava EM and Kosma VM: Reduced expression of alpha catenin is
associated with poor prognosis in colorectal carcinoma. J Clin
Pathol. 52:10–16. 1999. View Article : Google Scholar : PubMed/NCBI
|
21.
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
22.
|
Lauper N, Beck AR, Cariou S, Richman L, et
al: Cyclin E2: a novel CDK2 partner in the late G1 and S phases of
the mammalian cell cycle. Oncogene. 17:2637–2643. 1998. View Article : Google Scholar : PubMed/NCBI
|
23.
|
Lundberg AS and Weinberg RA: Functional
inactivation of the retinoblastoma protein requires sequential
modification by at least two distinct cyclin-cdk complexes. Mol
Cell Biol. 18:753–761. 1998.PubMed/NCBI
|
24.
|
Cory G: Scratch-wound assay. Methods Mol
Biol. 769:25–30. 2011. View Article : Google Scholar
|
25.
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
26.
|
Maass N, Hojo T, Ueding M, Lüttges J, et
al: Expression of the tumor suppressor gene Maspin in human
pancreatic cancers. Clin Cancer Res. 7:812–817. 2001.PubMed/NCBI
|
27.
|
El-Mansi MT and Williams AR: Evaluation of
PTEN expression in cervical adenocarcinoma by tissue microarray.
Int J Gynecol Cancer. 16:1254–1260. 2006. View Article : Google Scholar : PubMed/NCBI
|
28.
|
Lee JS, Choi YD, Lee JH, Nam JH, et al:
Expression of PTEN in the progression of cervical neoplasia and its
relation to tumor behavior and angiogenesis in invasive squamous
cell carcinoma. J Surg Oncol. 93:233–240. 2006. View Article : Google Scholar : PubMed/NCBI
|
29.
|
He L, Ingram A, Rybak AP and Tang D:
Shank-interacting protein-like 1 promotes tumorigenesis via PTEN
inhibition in human tumor cells. J Clin Invest. 120:2094–2108.
2010. View
Article : Google Scholar : PubMed/NCBI
|
30.
|
Looman C, Abrink M, Mark C and Hellman L:
KRAB zinc finger proteins: an analysis of the molecular mechanisms
governing their increase in numbers and complexity during
evolution. Mol Biol Evol. 19:2118–2130. 2002. View Article : Google Scholar : PubMed/NCBI
|